In this issue:
Beta-cell function recovery with low-dose insulin in type 2 diabetes
ACCORD: intensive glycaemic lowering and HRQOL
Intradermal microneedle vs. SC insulin lispro
Vildagliptin: Beta-cell in type 2 diabetes EPIC:
Mortality risk and low HbA1c in nondiabetics
Please login below to download this issue (PDF)